What is the ROE (Return on Equity) of AbbVie this year?
The ROE of AbbVie this year is 0.47 undefined.
AbbVie ROE 2024
AbbVie ROE
0.47
Ticker
ABBV
ISIN
US00287Y1091
WKN
A1J84E
In 2024, AbbVie's return on equity (ROE) was 0.47, a -31.87% increase from the 0.68 ROE in the previous year.
AbbVie Aktienanalyse
What does AbbVie do?
Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines. AbbVie ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding AbbVie's Return on Equity (ROE)
AbbVie's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing AbbVie's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
AbbVie's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in AbbVie’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about AbbVie stock
How has the Return on Equity (ROE) of AbbVie developed compared to the previous year?
The ROE of AbbVie has increased by -31.87% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of AbbVie?
A high ROE indicates that AbbVie generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of AbbVie?
A low ROE can indicate that AbbVie is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of AbbVie affect the company?
A change in ROE (Return on Equity) of AbbVie can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of AbbVie?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of AbbVie?
Some factors that can influence AbbVie's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does AbbVie pay?
Over the past 12 months, AbbVie paid a dividend of 5.92 USD . This corresponds to a dividend yield of about 3.37 %. For the coming 12 months, AbbVie is expected to pay a dividend of 6.04 USD.
What is the dividend yield of AbbVie?
The current dividend yield of AbbVie is 3.37 %.
When does AbbVie pay dividends?
AbbVie pays a quarterly dividend. This is distributed in the months of May, August, November, February.
How secure is the dividend of AbbVie?
AbbVie paid dividends every year for the past 101 years.
What is the dividend of AbbVie?
For the upcoming 12 months, dividends amounting to 6.04 USD are expected. This corresponds to a dividend yield of 3.44 %.
In which sector is AbbVie located?
AbbVie is assigned to the 'Health' sector.
Wann musste ich die Aktien von AbbVie kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of AbbVie from 11/15/2024 amounting to 1.55 USD, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did AbbVie pay the last dividend?
The last dividend was paid out on 11/15/2024.
What was the dividend of AbbVie in the year 2023?
In the year 2023, AbbVie distributed 5.64 USD as dividends.
In which currency does AbbVie pay out the dividend?
The dividends of AbbVie are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The AbbVie stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von AbbVie
Our stock analysis for AbbVie Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AbbVie Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
